FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Pharmaceuticals Esomeprazole Magnesium Delayed-Release Recall

Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Nov 29, 2023
Recall ID
D-0112-2024
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Esomeprazole Magnesium Delayed-Release starting Oct 23, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0112-2024 on Nov 29, 2023. Reason: Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH). Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).

Product description

Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India,

Lot numbers, UPCs & expiration codes

Lot # 17220002, Exp Date 11/30/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0112-2024
Classification
Class III
Status
Terminated
Recall initiated
Oct 23, 2023
FDA report date
Nov 29, 2023
Quantity
8,448 30-count bottles, 168 1000-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0112-2024, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
93262
Address
750 Corporate Dr
Code information
Lot # 17220002, Exp Date 11/30/2023
Postal code
07430-2009
Report date
Nov 29, 2023
Product type
Drugs
Recall number
D-0112-2024
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
8,448 30-count bottles, 168 1000-count bottles
Termination date
Jul 5, 2024
Reason for recall
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India,
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 23, 2023
Initial firm notification
Letter
Center classification date
Nov 20, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0112-2024, published Nov 29, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls